iRhythm Technologies (NASDAQ: IRTC) reported mixed Q4 results but predicted strong sales growth in 2021. The San Francisco–based company — maker of the Zio ambulatory cardiac monitoring patch — reported a loss of –$9.7 million, or –33¢ per share, on sales of $78.8 million for the three months ended Dec. 31, 2020, nearly halving its […]
iRhythm Technologies Inc.
iRhythm Zio 10 times more effective in identifying Afib, study says
iRhythm Technologies (NSDQ:IRTC) today touted study results that found its Zio device was more effective in detecting Afib than standard care. Published in JAMA Cardiology, the SCREEN-AF study showed that the use of Zio by iRhythm led to a tenfold increase in the detection of Afib when compared to patients receiving standard clinical care. One of […]
MedTech 100 roundup: Rise to new heights continues
The medtech industry hit another high as 2021 continues to bring strong performances out of some of the biggest companies around. MassDevice‘s MedTech 100 index ended the week (Feb. 12) at 110.63 points, marking a 2.2% rise from the 108.23-point mark set at the end of the previous week (Feb. 5). The final mark for the […]
DTW #45: Kamen talks 3D organs; Todd Pope returns as CEO; Joe Mulling says medtech’s time is now
Please lift this jam-packed episode with your legs, not your back. We’ll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech. WellAir’s Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID Joe Mullings of the Mullings Group explains why now is […]
How new CEO Mike Coyle plans to lead iRhythm forward
Taking over as CEO of a medtech company in the midst of a pandemic doesn’t seem ideal, but former Medtronic executive Mike Coyle was thrilled to take the helm of iRhythm Technologies (NSDQ:IRTC) in January 2021. The company had had a banner year in 2020, and Coyle believes it has a bright future in a space that […]
These medtech stocks performed the best in 2020
While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while […]
Mike Coyle leaving Medtronic to become CEO of iRhythm
iRhythm Technologies (NSDQ:IRTC) announced that president & CEO Kevin King will retire; longtime Medtronic executive Mike Coyle will move to iRhythm and take over the corner office. King’s departure will be made effective on Jan. 12, 2021, while Coyle will join as president & CEO and as a member of the board of directors on the […]
UK regulators recommend iRhythm cardiac arrythmia device
iRhythm Technologies (NSDQ:IRTC) announced that it received a recommendation for adoption from National Institute for Health and Care Excellence (NICE). San Francisco-based iRhythm said in a news release that it is the first technology to pass through a new digital health tech pilot, resulting in the successful recommendation for adoption from NICE. The company’s Zio XT […]
MedTech 100 roundup: Industry reaches new heights again
The past month has seen a resurgence from medtech companies in the markets and last week saw the best performance yet. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 90.78 points at the end of last week (Aug. 28). Overall, medtech stocks saw a 1.3% increase […]
DTW Podcast: Truist’s Kaila Krum says Medtronic prepping for growth
In an interview with DeviceTalks Weekly Podcast, Truist Securities managing director Kaila Krum says Medtronic executives are retooling the company to keep pace with smaller, more focused competitors. Breaking down the company’s Q1 call, Krum says Medtronic is seen as a company that’s too big to grow market share quickly. On the call, new CEO […]
The top 5 MassDevice stories of the week — August 28, 2020
As earnings season concludes and the COVID-19 pandemic roars on, medtech companies continue to find new ways to make waves. This week’s top five MassDevice stories showcase how companies are operating in the “new normal,” as they look toward the post-pandemic future, whenever that may arrive. Strong quarterly earnings, big funding rounds and new innovations in […]